Despite the circumstantial evidence, the underlying mechanism through which androgens and loss of ERβ influence c-FLIP deregulation during prostate carcinogenesis and whether 2-ME2-mediated inhibition of prostate tumor development involves ERβ/c-FLIP remains to be defined. Here, ESR2 is linked to urogenital neoplasm.